Quantiphi has acquired a strategic minority interest in Transcell, a biotech innovator specializing in stem cell technology..The partnership aims to combine Quantiphi's AI expertise with Transcell's stem cell technology to accelerate drug discovery and development..One of the goals is to reduce reliance on animal testing by using AI and stem cell-based methods..The collaboration focuses on developing practical applications for adult stem cell technology to improve patient outcomes..By leveraging AI, the partnership seeks to make drug discovery processes faster, more efficient, and safer..Read More Stories
Quantiphi has acquired a strategic minority interest in Transcell, a biotech innovator specializing in stem cell technology..The partnership aims to combine Quantiphi's AI expertise with Transcell's stem cell technology to accelerate drug discovery and development..One of the goals is to reduce reliance on animal testing by using AI and stem cell-based methods..The collaboration focuses on developing practical applications for adult stem cell technology to improve patient outcomes..By leveraging AI, the partnership seeks to make drug discovery processes faster, more efficient, and safer..Read More Stories